Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.8700
-0.0378 (-4.16%)
At close: May 30, 2025, 4:00 PM
0.8708
+0.0008 (0.09%)
After-hours: May 30, 2025, 7:29 PM EDT
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $12.29 million as of May 30, 2025. Its market cap has increased by 9.74% in one year.
Market Cap
12.29M
Enterprise Value
5.02M
1-Year Change
9.74%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $12.29M, a decrease of -82.62%. That is a compound annual growth rate of -17.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 12.30M | 141.18% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |